Cargando…
Challenges of Precision Medicine for Atherosclerotic Cardiovascular Disease Based on Human Genome Information
Precision or personalized medicine is currently gaining a lot of attention. Clinical evidence for its effectiveness has been established based on randomized clinical trials accounting for classical risk factors, such as hypertension, diabetes, and serum lipids. However, besides such classical risk f...
Autores principales: | Tada, Hayato, Usui, Soichiro, Sakata, Kenji, Takamura, Masayuki, Kawashiri, Masa-aki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147010/ https://www.ncbi.nlm.nih.gov/pubmed/33229815 http://dx.doi.org/10.5551/jat.60087 |
Ejemplares similares
-
Impact of the severe familial hypercholesterolemia status on atherosclerotic risks
por: Tada, Hayato, et al.
Publicado: (2023) -
The Assessment of Carotid Atherosclerotic Plaque among Young Patients with Familial Hypercholesterolemia
por: Shibayama, Junichi, et al.
Publicado: (2022) -
Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease
por: Tada, Hayato, et al.
Publicado: (2019) -
Low-Density Lipoprotein Cholesterol Level cannot be too Low: Considerations from Clinical Trials, Human Genetics, and Biology
por: Tada, Hayato, et al.
Publicado: (2020) -
Eggplant-Like Coronary Aneurysm With Massive Thrombus
por: Yamagami, Kan, et al.
Publicado: (2022)